Pyxis Oncology, Inc.
NASDAQ:PYXS
3.68 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 26.546 | 29.439 | 11.136 | 14.715 | 25.898 | 53.059 | 179.293 | 198.538 | 223.355 | 247.087 | 274.735 | 133.477 | 142.473 | -8.08 | 8.08 | -19.69 |
| Short Term Investments
| 130.65 | 129.06 | 109.634 | 118.252 | 116.765 | 96.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.16 | 0 | 39.38 |
| Cash and Short Term Investments
| 157.196 | 158.499 | 120.77 | 132.967 | 142.663 | 149.349 | 179.293 | 198.538 | 223.355 | 247.087 | 274.735 | 133.477 | 142.473 | 8.08 | 8.08 | 19.69 |
| Net Receivables
| 0 | 8 | 0.021 | 0 | 0 | 0 | 0.598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 6.34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.842 | 5.88 | 3.813 | 4.655 | 5.169 | 5.361 | 0.381 | 2.798 | 1.768 | 2.698 | 0.084 | 0.859 | 0.471 | 0 | 0.015 | 0 |
| Total Current Assets
| 161.038 | 172.379 | 124.604 | 139.094 | 149.304 | 156.182 | 186.612 | 202.808 | 226.595 | 251.257 | 278.673 | 134.336 | 142.944 | 8.08 | 8.103 | 19.69 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 23.676 | 24.111 | 24.814 | 25.304 | 25.926 | 26.621 | 24.767 | 21.087 | 15.968 | 0.995 | 1.239 | 1.542 | 1.854 | 0 | 1.939 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 23.675 | 23.73 | 24.308 | 22.294 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 23.675 | 23.73 | 24.308 | 22.294 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.449 | 0.109 | 3.61 | 2.251 | -8.08 | 0.109 | -19.69 |
| Total Non-Current Assets
| 47.351 | 47.841 | 49.122 | 47.598 | 25.926 | 26.621 | 24.767 | 21.087 | 15.968 | 1.444 | 1.348 | 5.152 | 4.105 | -8.08 | 2.048 | -19.69 |
| Total Assets
| 208.389 | 220.22 | 173.726 | 186.692 | 175.23 | 182.803 | 211.379 | 223.895 | 242.563 | 252.701 | 280.021 | 139.488 | 147.049 | 0 | 10.151 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 5.47 | 2.293 | 3.896 | 3.31 | 1.305 | 4.025 | 7.097 | 5.509 | 7.82 | 2.055 | 11.951 | 1.927 | 1.266 | 0 | 1.077 | 0 |
| Short Term Debt
| 1.338 | 1.02 | 1.232 | 1.204 | 0.527 | 1.213 | 0 | 0 | 0 | 0 | 0.165 | 0.325 | 0.481 | 0 | 0.615 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.064 | 0 |
| Deferred Revenue
| 0 | 0 | 7.66 | 7.189 | 0 | 0 | 0 | 0 | 0 | 0 | 6.326 | 5.462 | 2.237 | 0 | 1.945 | 0 |
| Other Current Liabilities
| 10.089 | 10.828 | 12.971 | 16.629 | 7.393 | 6.363 | 24.537 | 13.586 | 7.096 | 17.132 | 0.266 | 9.123 | 4.428 | 0 | 0.052 | 0 |
| Total Current Liabilities
| 16.897 | 14.141 | 25.759 | 28.332 | 9.225 | 11.601 | 31.634 | 19.095 | 14.916 | 19.187 | 18.708 | 16.837 | 8.412 | 0 | 3.689 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 19.534 | 19.759 | 20.099 | 20.414 | 20.73 | 19.039 | 18.921 | 16.053 | 15.681 | 0 | 0.165 | 0 | 0 | 0 | 0.165 | 0 |
| Deferred Revenue Non-Current
| 0 | -2.164 | 2.164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.164 | 2.164 | 2.164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 2.164 | -2.164 | 0 | 0 | 0 | 0 | 0 | 0 | 2.055 | 11.951 | 194.09 | 196.225 | 0 | 21.942 | 0 |
| Total Non-Current Liabilities
| 21.698 | 21.923 | 22.263 | 20.414 | 20.73 | 19.039 | 18.921 | 16.053 | 15.681 | 2.055 | 12.116 | 194.09 | 196.225 | 0 | 22.107 | 0 |
| Total Liabilities
| 38.595 | 36.064 | 48.022 | 48.746 | 29.955 | 30.64 | 50.555 | 35.148 | 30.597 | 19.187 | 18.708 | 210.927 | 204.637 | 0 | 25.796 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.942 | 172.081 | 21.942 | 21.942 | 21.942 |
| Common Stock
| 0.059 | 0.059 | 0.045 | 0.044 | 0.039 | 0.037 | 0.034 | 0.032 | 0.032 | 0.032 | 0.032 | 0.002 | 0.002 | 0 | 0.001 | 0 |
| Retained Earnings
| -306.782 | -289.481 | -286.225 | -270.628 | -247.579 | -231.678 | -212.435 | -176.334 | -148.66 | -123.098 | -91.718 | -74.889 | -60.714 | 0 | -15.743 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.102 | -0.06 | 0.063 | -0.105 | -0.085 | 0.696 | 0 | 0 | 0 | 0 | -0 | -21.942 | 0 | -15.645 | 0 | -2.874 |
| Other Total Stockholders Equity
| 476.619 | 473.638 | 411.821 | 408.635 | 392.9 | 383.108 | 373.225 | 365.049 | 360.594 | 356.58 | 352.999 | 3.448 | -168.957 | 0 | -21.845 | 0 |
| Total Shareholders Equity
| 169.794 | 184.156 | 125.704 | 137.946 | 145.275 | 152.163 | 160.824 | 188.747 | 211.966 | 233.514 | 261.313 | -71.439 | -57.588 | 6.297 | -15.645 | 19.068 |
| Total Equity
| 169.794 | 184.156 | 125.704 | 137.946 | 145.275 | 152.163 | 160.824 | 188.747 | 211.966 | 233.514 | 261.313 | -71.439 | -57.588 | 6.297 | -15.645 | 19.068 |
| Total Liabilities & Shareholders Equity
| 208.389 | 220.22 | 173.726 | 186.692 | 175.23 | 182.803 | 211.379 | 223.895 | 242.563 | 252.701 | 280.021 | 139.488 | 147.049 | 6.297 | 10.151 | 19.068 |